Nefopam

Suppliers

Names

[ CAS No. ]:
13669-70-0

[ Name ]:
Nefopam

[Synonym ]:
5-Methyl-1-phenyl-3,4,5,6-tetrahydro-1H-2,5-benzoxazocine
Sinalgico
EINECS 237-148-2
5-methyl-1-phenyl-3,4,5,6-tetrahydro-1H-2,5-benzoxazocine hydrochloride
5-Methyl-1-phenyl-3,4,5,6-tetrahydro-1H-benzo[f][1,4]oxazocine
Ajan
1H-2,5-Benzoxazocine, 3,4,5,6-tetrahydro-5-methyl-1-phenyl-
3,4,5,6-Tetrahydro-5-methyl-1-phenyl-1H-2,5-benzoxazocine
Nefopam
MFCD00056181
Acupan

Chemical & Physical Properties

[ Density]:
1.1±0.1 g/cm3

[ Boiling Point ]:
369.5±37.0 °C at 760 mmHg

[ Molecular Formula ]:
C17H19NO

[ Molecular Weight ]:
253.339

[ Flash Point ]:
109.0±28.8 °C

[ Exact Mass ]:
253.146667

[ PSA ]:
12.47000

[ LogP ]:
3.44

[ Vapour Pressure ]:
0.0±0.8 mmHg at 25°C

[ Index of Refraction ]:
1.564

[ Storage condition ]:
2-8°C

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
DM4210000
CHEMICAL NAME :
1H-2,5-Benzoxazocine, 3,4,5,6,7-tetrahydro-5-methyl-1-phenyl-
CAS REGISTRY NUMBER :
13669-70-0
LAST UPDATED :
199703
DATA ITEMS CITED :
4
MOLECULAR FORMULA :
C17-H19-N-O
MOLECULAR WEIGHT :
253.37
WISWESSER LINE NOTATION :
T68 HN KO&TJ H1 LR

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human - woman
DOSE/DURATION :
15 mg/kg
TOXIC EFFECTS :
Behavioral - changes in motor activity (specific assay) Cardiac - change in rate
REFERENCE :
BMJOAE British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- Volume(issue)/page/year: 283,1508,1981
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human - man
DOSE/DURATION :
17 mg/kg
TOXIC EFFECTS :
Behavioral - hallucinations, distorted perceptions Behavioral - excitement Cardiac - pulse rate increase, without fall in BP
REFERENCE :
BMJOAE British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- Volume(issue)/page/year: 283,1508,1981
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
180 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #4198424
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
50 mg/kg
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - mydriasis (pupillary dilation)
REFERENCE :
DDEVD6 Drug Development and Evaluation. (Gustav Fischer Verlag, Postfach 720143, D-7000 Stuttgart 70, Fed. Rep. Ger.) V.1- 1977- Volume(issue)/page/year: 3,10,1979

Safety Information

[ HS Code ]:
2933990090

Synthetic Route

Precursor & DownStream

Precursor

  • Nefopam hydrochloride
  • 2-(1-PHENYL-2,3-DIHYDRO-1H-ISOINDOL-2-YL)ETHANOL
  • 1-PHENYL-3,4,5,6-TETRAHYDRO-1H-2,5-BENZOXAZOCINE-5-CARBONITRILE

DownStream

  • Iodomethane-d3

Customs

[ HS Code ]: 2933990090

[ Summary ]:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%


Related Compounds

  • Nefopam D3
  • Nefopam HCl
  • nor-nefopam
  • Nefopam N-Oxide
  • Nefopam-d3 N-Oxide
  • Nefopam Impurity 6
  • 2-(Azetidin-3-yloxy)pyrimidine;2,2,2-trifluoroacetic acid
  • 9-Oxa-2-azaspiro[5.5]undecane-3-carboxylic acid;hydrochloride
  • 2-Amino-3-(5,6-dichloropyridin-3-yl)propanoic acid;dihydrochloride
  • 7,7-Difluoro-1-azaspiro[3.5]nonane;hydrochloride
  • 3-Methylpyridine-2,4-dicarboxylicacidhydrochloride
  • 2-Amino-3-(2-bromopyridin-4-yl)propanoic acid;dihydrobromide
  • (1R)-1-[5-(Aminomethyl)-1H-1,2,4-triazol-3-yl]ethanol;hydrochloride
  • 4-(1-Hydrazinylethyl)benzoic acid hydrochloride
  • (2S)-2-[[(2R)-2-Amino-4-methylpentanoyl]amino]-3-methylbutanoic acid;hydrochloride
  • (2R)-2-[[(2S)-2-Amino-4-methylpentanoyl]amino]-3-methylbutanoic acid;hydrochloride
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.